First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study
Prenatal Diagnosis · 2026
DOI: 10.1002/pd.70260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Prenatal Diagnosis, 2026. Verfasst von Catalina De Paco Matallana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, "Virgen de la Arrixaca" University Hospital, Murcia, Spain. Hauptthemen laut MEDLINE: Pregnancy Trimester, First, Cell-Free Nucleic Acids, Trisomy. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Partial funding for this study was provided by Vanadis Diagnostics AB, a Revvity Inc. company, through the Foundation for Health Research and Training in the R….
Abstract (Originalsprache)
Objective
To evaluate cell‐free DNA screening for trisomies 21, 18 and 13 using rolling circle replication in an unselected routine first‐trimester screening population.
Method
This study enrolled 3025 women undergoing first‐trimester screening. Excluding unavailable samples, missing outcome data, pregnancy loss and twin gestation, 2729 pregnancies with follow‐up remained; 2689 had cell‐free DNA results for performance analysis. Cell‐free fetal DNA was assessed by rolling circle replication and digital fluorescence detection without PCR or sequencing. Performance was confirmed with cytogenetic results or postnatal outcomes.
Results
Among 2729 eligible singleton pregnancies with follow‐up, valid cfDNA results were obtained in 2689 cases, corresponding to an overall no‐call rate of 40/2729 (1.47%). For trisomy 21, sensitivity was 14/14 (100%; 95% CI, 76.8–100), specificity was 2666/2675 (99.7%; 95% CI, 99.4–99.8), and PPV was 14/23 (60.9%; 95% CI, 38.5–80.3). For trisomy 18, sensitivity was 1/2 (50.0%; 95% CI, 1.3–98.7), specificity was 2681/2687 (99.8%; 95% CI, 99.5–99.9), and PPV was 1/7 (14.3%; 95% CI, 0.4–57.9). No confirmed trisomy 13 cases were observed. Fetal sex was correctly assigned in 2657/2688 cases (98.8%). Testing before 10 weeks' gestation and in IVF pregnancies appeared technically feasible, but these subgroup findings were limited by small numbers.
Conclusions
Rolling circle replication‐based cell‐free DNA screening showed high accuracy for trisomy 21 and fetal sex determination in this unselected routine first‐trimester screening population. However, the small number of trisomy 18 and trisomy 13 cases limits conclusions for these aneuploidies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, "Virgen de la Arrixaca" University Hospital, Murcia, Spain.
- Department of Obstetrics and Gynecology, Pediatrics and Surgery, University of Murcia, Murcia, Spain.
- Maternal-Fetal Medicine, Reproduction and Gynecology Research Group, Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, Murcia, Spain.
- Vanadis Diagnostics AB, a Revvity Inc Company, Sollentuna, Sweden.
- Fetal Medicine Research Institute, King's College Hospital, London, UK.
ORCID-Profile: Catalina De Paco Matallana, Javier Sánchez Romero, Miriam Pertegal, Juan Luis Delgado
Förderung
- Partial funding for this study was provided by Vanadis Diagnostics AB, a Revvity Inc. company, through the Foundation for Health Research and Training in the R…
Zitieren
APA
Matallana, C. P., Romero, J. S., Pertegal, M., Delgado, J. L., Ramfjord, E., & Nicolaides, K. H. (2026). First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study. Prenatal Diagnosis. https://doi.org/10.1002/pd.70260
Vancouver
Matallana CP, Romero JS, Pertegal M, Delgado JL, Ramfjord E, Nicolaides KH. First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study. Prenatal Diagnosis. 2026. doi:10.1002/pd.70260
BibTeX
@article{Matallana2026,
author = {Matallana, Catalina De Paco and Romero, Javier Sánchez and Pertegal, Miriam and Delgado, Juan Luis and Ramfjord, Erica and Nicolaides, Kypros H},
title = {First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study},
journal = {Prenatal Diagnosis},
year = {2026},
doi = {10.1002/pd.70260}
}
EUVIMED